Selective and reversible inhibitors of ubiquitin-specific protease 7: a patent evaluation (WO2013030218).

The invention described in this review (WO2013030218) relates to compounds based on the quinazolin-4-one scaffold, their process of preparation and applications to inhibit the ubiquitin-specific protease 7 (USP7), a deubiquitinating enzyme (DUB), which is considered a potentially important new drug...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας: Kessler, B
Μορφή: Journal article
Γλώσσα:English
Έκδοση: Informa Healthcare 2014